NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development-Reference-Cited by-同舟云学术

NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development

Published:2018-09-17 Issue:10 Volume:19 Page:1083-1092
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Jelenčić Vedrana,Šestan Marko,Kavazović Inga,Lenartić Maja,Marinović Sonja,Holmes Tim D.,Prchal-Murphy Michaela,Lisnić Berislav,Sexl Veronika,Bryceson Yenan T.^ORCID,Wensveen Felix M.^ORCID,Polić Bojan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41590-018-0209-9.pdf

Reference49 articles.

1. Spits, H., Bernink, J. H. & Lanier, L. NK cells and type 1 innate lymphoid cells: partners in host defense. Nat. Immunol. 17, 758–764 (2016).

2. Elliott, J. M. & Yokoyama, W. M. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol. 32, 364–372 (2011).

3. Long, E. O., Kim, H. S., Liu, D., Peterson, M. E. & Rajagopalan, S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31, 227–258 (2013).

4. Koch, J., Steinle, A., Watzl, C. & Mandelboim, O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 34, 182–191 (2013).

5. Zafirova, B., Wensveen, F. M., Gulin, M. & Polić, B. Regulation of immune cell function and differentiation by the NKG2D receptor. Cell. Mol. Life Sci. 68, 3519–3529 (2011).

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA sequencing analysis reveals the distinct features of colorectal cancer with or without Fusobacterium nucleatum infection in PD-L1 blockade therapy;Heliyon;2024-09

2. Maintaining the Balance: Regulation of NK Cell Activity;Cells;2024-08-31

3. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy;Pharmaceutics;2024-08-29

4. Unlocking the power of immunotherapy: Combinatorial delivery of plasmid IL-15 and gemcitabine to synergistically remodeling the tumor microenvironment;International Journal of Pharmaceutics;2024-04

5. Enhancing cancer immunotherapy with Anti-NKG2D/IL-15(N72D)/Sushi fusion protein: Targeting cytotoxic immune cells and boosting IL-15 efficacy;Cytokine;2024-04